BIODESIX INC
Current- Director 2008 to present
Executive record
Alpha ID: alpha:person:john-patienceVersion: public-0As of: 2026-10-03
Connect capital, control, accountability, and evidence.
Chairman of Biodesix since September 2020. Founding partner of Crabtree Partners private equity firm and former partner at McKinsey & Company specializing in healthcare. Served as Vice Chairman of Ventana Medical Systems and director since 1989 until its acquisition by Roche in 2008. Holds B.A. in Liberal Arts and L.L.B. from University of Sydney and M.B.A. from Wharton.
Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageAlpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.
Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.
4 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
sec filing · Source published: Apr 9, 2026 · Retrieved: May 15, 2026
sec filing · Source published: Apr 9, 2026 · Retrieved: May 15, 2026
sec proxy · Source published: Apr 9, 2026 · Retrieved: Apr 24, 2026
public source · Source published: Date unavailable · Retrieved: Date unavailable
No published record changes are available in this projection.
Identity
unclaimed
Evidence
corroborated
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-10-03